273 related articles for article (PubMed ID: 11425508)
1. Estrogen-like activity of tamoxifen and raloxifene on NMDA receptor binding and expression of its subunits in rat brain.
Cyr M; Thibault C; Morissette M; Landry M; Di Paolo T
Neuropsychopharmacology; 2001 Aug; 25(2):242-57. PubMed ID: 11425508
[TBL] [Abstract][Full Text] [Related]
2. Changes in 5-HT1A receptor binding and G-protein activation in the rat brain after estrogen treatment: comparison with tamoxifen and raloxifene.
Le Saux M; Di Paolo T
J Psychiatry Neurosci; 2005 Mar; 30(2):110-7. PubMed ID: 15798786
[TBL] [Abstract][Full Text] [Related]
3. Modulation by estrogen-receptor directed drugs of 5-hydroxytryptamine-2A receptors in rat brain.
Cyr M; Landry M; Di Paolo T
Neuropsychopharmacology; 2000 Jul; 23(1):69-78. PubMed ID: 10869887
[TBL] [Abstract][Full Text] [Related]
4. Effect of oestrogen receptor alpha and beta agonists on brain N-methyl-D-aspartate receptors.
Morissette M; Le Saux M; Di Paolo T
J Neuroendocrinol; 2008 Aug; 20(8):1006-14. PubMed ID: 18510708
[TBL] [Abstract][Full Text] [Related]
5. Effect of chronic estradiol, tamoxifen or raloxifene treatment on serotonin 5-HT1A receptor.
Landry M; Di Paolo T
Brain Res Mol Brain Res; 2003 Apr; 112(1-2):82-9. PubMed ID: 12670705
[TBL] [Abstract][Full Text] [Related]
6. Estrogenic properties of raloxifene, but not tamoxifen, on D2 and D3 dopamine receptors in the rat forebrain.
Landry M; Lévesque D; Di Paolo T
Neuroendocrinology; 2002 Oct; 76(4):214-22. PubMed ID: 12411738
[TBL] [Abstract][Full Text] [Related]
7. Ovarian steroids and selective estrogen receptor modulators activity on rat brain NMDA and AMPA receptors.
Cyr M; Ghribi O; Thibault C; Morissette M; Landry M; Di Paolo T
Brain Res Brain Res Rev; 2001 Nov; 37(1-3):153-61. PubMed ID: 11744083
[TBL] [Abstract][Full Text] [Related]
8. Regional and selective effects of oestradiol and progesterone on NMDA and AMPA receptors in the rat brain.
Cyr M; Ghribi O; Di Paolo T
J Neuroendocrinol; 2000 May; 12(5):445-52. PubMed ID: 10792584
[TBL] [Abstract][Full Text] [Related]
9. Estrogenic activity of tamoxifen and raloxifene on rat brain AMPA receptors.
Cyr M; Morissette M; Landry M; Di Paolo T
Neuroreport; 2001 Mar; 12(3):535-9. PubMed ID: 11234759
[TBL] [Abstract][Full Text] [Related]
10. Regulation of progesterone receptor messenger ribonucleic acid in the rat medial preoptic nucleus by estrogenic and antiestrogenic compounds: an in situ hybridization study.
Shughrue PJ; Lane MV; Merchenthaler I
Endocrinology; 1997 Dec; 138(12):5476-84. PubMed ID: 9389534
[TBL] [Abstract][Full Text] [Related]
11. Length of postovariectomy interval and age, but not estrogen replacement, regulate N-methyl-D-aspartate receptor mRNA levels in the hippocampus of female rats.
Adams MM; Oung T; Morrison JH; Gore AC
Exp Neurol; 2001 Aug; 170(2):345-56. PubMed ID: 11476600
[TBL] [Abstract][Full Text] [Related]
12. Chronic estrogenic drug treatment increases preproenkephalin mRNA levels in the rat striatum and nucleus accumbens.
Le Saux M; Di Paolo T
Psychoneuroendocrinology; 2005 Apr; 30(3):251-60. PubMed ID: 15511599
[TBL] [Abstract][Full Text] [Related]
13. Differential expression of NMDA and AMPA receptor subunits in rat dorsal and ventral hippocampus.
Pandis C; Sotiriou E; Kouvaras E; Asprodini E; Papatheodoropoulos C; Angelatou F
Neuroscience; 2006 Jun; 140(1):163-75. PubMed ID: 16542781
[TBL] [Abstract][Full Text] [Related]
14. Transient global ischemia in rat brain promotes different NMDA receptor regulation depending on the brain structure studied.
Dos-Anjos S; Martínez-Villayandre B; Montori S; Regueiro-Purriños MM; Gonzalo-Orden JM; Fernández-López A
Neurochem Int; 2009; 54(3-4):180-5. PubMed ID: 19103243
[TBL] [Abstract][Full Text] [Related]
15. Estradiol selectively regulates agonist binding sites on the N-methyl-D-aspartate receptor complex in the CA1 region of the hippocampus.
Weiland NG
Endocrinology; 1992 Aug; 131(2):662-8. PubMed ID: 1353442
[TBL] [Abstract][Full Text] [Related]
16. Effect of oestrogen receptors on brain NMDA receptors of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine mice.
Al-Sweidi S; Morissette M; Di Paolo T
J Neuroendocrinol; 2012 Nov; 24(11):1375-85. PubMed ID: 22672467
[TBL] [Abstract][Full Text] [Related]
17. Effects of two novel selective estrogen receptor modulators, raloxifene, tamoxifen, and ethinyl estradiol on the uterus, vagina and breast in ovariectomized cynomolgus monkeys (Macaca fascicularis).
Sikoski P; Register TC; Lees CJ; Lundeen S; Hutchison J; Brown KH; Cline JM
Am J Obstet Gynecol; 2007 Jan; 196(1):75.e1-7. PubMed ID: 17240242
[TBL] [Abstract][Full Text] [Related]
18. Native N-methyl-D-aspartate receptors containing NR2A and NR2B subunits have pharmacologically distinct competitive antagonist binding sites.
Christie JM; Jane DE; Monaghan DT
J Pharmacol Exp Ther; 2000 Mar; 292(3):1169-74. PubMed ID: 10688637
[TBL] [Abstract][Full Text] [Related]
19. Raloxifene blocks estradiol induction of the serotonin transporter and 5-hydroxytryptamine2A receptor in female rat brain.
Sumner BE; Grant KE; Rosie R; Hegele-Hartung Ch; Fritzemeier KH; Fink G
Neurosci Lett; 2007 Apr; 417(1):95-9. PubMed ID: 17398000
[TBL] [Abstract][Full Text] [Related]
20. Raloxifene, tamoxifen, nafoxidine, or estrogen effects on reproductive and nonreproductive tissues in ovariectomized rats.
Sato M; Rippy MK; Bryant HU
FASEB J; 1996 Jun; 10(8):905-12. PubMed ID: 8666168
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
